GUILFORD, Conn.–(BUSINESS WIRE)–Apr. 18, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will report financial results for the first quarter 2022 after market close on Monday, 9 Maggio 2022. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 p.m. ET.
Individuals interested in the listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can participate in the call by dialing (833) 927-1758 for domestic callers or (929) 526-1599 for international callers, followed by Conference ID: 600467. An archived webcast of the event will be available for replay following the event.
About Quantum-Si Incorporated
Quantum-Si is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single molecule next-generation protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at www.quantum-si.com.
Contacts
Investor
Juan Avendano
Mike Cavanaugh
ir@quantum-si.com
Media
Jon Yu
QSI-PR@westwicke.com
